ARGATROBAN FOR INJECTION DIN 02561557
Health Canada record
| Active ingredient(s) | ARGATROBAN 100 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B01AE03 ARGATROBAN |
| Original market date | 07-Jan-2026 |
| Current status date | 07-Jan-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Juno Pharma Canada Inc. — licence 3-002916, currently licensed, last inspection rating C (2025-11-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ARGATROBAN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02548968 | ARGATROBAN | SANDOZ CANADA INCORPORATED | Solution | ARGATROBAN 1 MG | Marketed |
| 02243835 | ARGATROBAN | SANDOZ CANADA INCORPORATED | Solution | ARGATROBAN 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36100 | 2025-10-02 | Abbreviated New Drug Submission (ANDS) |
International API supply for ARGATROBAN
11 active FDA Drug Master Files.
Request a quote for ARGATROBAN FOR INJECTION